Take Care of Your “Health-Lite” Claims

Mar 14, 2024 by Author: Annie Ugurlayan, Assistant Director, National Advertising Division, BBB National Programs

Now more than ever consumers are paying attention to their health and wellness and in the last year the Federal Trade Commission (FTC) has proven that they are paying attention too. Their focus is on advertisers touting the benefits and unique health-related features of their products.

Some advertisers believe they can avoid the scrutiny of regulators and the National Advertising Division (NAD) when making health-related claims by making their claim “softer.” An example would be trying to use ingredient claims instead, such as “Formulated with X” or adding that the product “helps” to treat a health-related condition.   

But context is key. If this claim is associated with health benefits, then advertisers must be mindful of the FTC’s Health Products Compliance Guidance, which was updated at the end of 2022 to replace the FTC’s 1998 Dietary Supplements. 

The substantiation bar is not lowered by changing the approach to the health-related claim. If you tout the presence of an ingredient in your product as providing a health benefit, consumers may understand that your product confers that benefit so you must have competent and reliable scientific evidence to support that implied takeaway.  

Similarly, if you qualify your claim to state that the product “helps to” or “may” confer a benefit, consumers understand the claim to mean that the product will provide some benefit, rather than understanding the qualifying language as a substantial disclaimer. 

Shortly after the updated Health Products guidance was released, the FTC put advertisers on notice, warning that claims about the health or safety benefits of a product must be truthful, not misleading, and most importantly substantiated with scientific evidence. 

When it comes to reliance on research, the guidance recommends that advertisers ensure that:

  • The research is both internally valid but also relevant to their specific product and to the specific advertised benefit. 
  • The research reflects the dosage and formulation of the advertised product as well as how well the outcomes tested in the study relate to the specific benefits advertised.
  • If there are significant discrepancies between research conditions and the real-life use being promoted, advertisers have evaluated whether it is appropriate to extrapolate from the research to the claimed effect.
  • The claims accurately reflect what the research shows.

 

Claims that don’t match the research results, no matter how sound that research is, are likely to be found as deceptive. The Health Guidance’s Example 23 is particularly instructive: 

“An advertiser conducts a literature search and finds several abstracts summarizing clinical studies about the association between a nutrient and the ability to perform better on memory tests. The advertiser relies on these summaries to support a claim that its supplement, which contains the same nutrient, aids memory. However, without looking carefully at the specifics of the study design, implementation, and results, there is no way for the advertiser to ascertain whether the research substantiates the product claims. (For example, did the research use a comparable formulation of the ingredient? Was the study adequately controlled? Did the study yield between-group results that are statistically significant?) Thus, the advertiser should carefully review the underlying science with the assistance of an expert before drafting advertising claims.”

These guiding principles inform health-related claims such as “our product lowers blood pressure” as well as “softer” claims. 

 

Takeaway Tips 

1. Quality, not quantity, of the research is what matters – multiple unreliable studies ≠ a reliable study.

2. When it comes to the science underlying ingredient claims, the product’s intended use and target population of your product are critical.

  • Studies on an elderly, diseased population are not a good fit for a product directed to a healthy general population.
  • Don’t forget about the dose, formulation, and method of administration: if the studied ingredients do not match the product, the study will be deemed unreliable to support product claims.

 

These important reminders can ensure that your claims pass muster before the FTC and NAD and provide useful information to consumers to make more informed purchasing decisions.  

Originally published by HBW Insight.

Suggested Articles

Blog

Old MacDonald Had an Engagement Farm: Lessons Learned from FTC v. NGL

Capturing user engagement is the foundation of internet commerce. And while the incentives to prompt greater engagement are certainly understandable, the recent NGL Labs case from the FTC raises important questions about the ethical and legal ramifications when companies try to artificially generate engagement among their userbase.
Read more
Blog

Independence Day Edition: CBPR Framework Offers “Checks & Balances”

Going, Going, Gone Global, a webinar on the CBPR Global Forum, delved into how privacy impacts businesses’ brand reputation and builds trust with key stakeholders, discussed the purpose of the Global CBPR, and its value to Global Forum members.
Read more
Blog

Industry Self-Regulation: Part of the Solution for Governing Generative AI

The spotlight on generative AI remains bright. The benefits and risks continue to be ever-present in the minds of business and political leaders. No matter the timing or the setting, the creation of transparency, accountability, and collaboration among stakeholders is key to successful industry self-regulation as is the importance of setting standards and best practices.
Read more
Blog

The Demise of “Chevron Deference”: Who Will Fill the Regulatory Gaps?

The Supreme Court's 1984 ruling in Chevron v. NRDC held that courts should defer to federal agencies’ interpretations of ambiguous federal laws so long as those interpretations are reasonable. So given the court’s decision to overturn it, where does that leave companies that want a level playing field and perhaps even to raise the bar, instead of racing to the bottom?
Read more